Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NABILONE 0.25MG CAPSULE Resolved 2021-11-25 2021-12-02 149942
TEVA-RISPERIDONE 0.25MG TABLET Resolved 2022-06-16 2022-09-08 162861
TEVA-NABILONE 0.25MG CAPSULE Resolved 2022-09-22 2023-04-28 169973
ACT PRAMIPEXOLE 0.25MG TABLET Resolved 2023-04-27 2024-01-11 190719
ACT PRAMIPEXOLE 0.25MG TABLET Resolved 2023-06-19 2023-07-05 195582
TEVA-ROPINIROLE 0.25MG TABLET Resolved 2023-06-26 2023-08-18 196471
TEVA-ROPINIROLE 0.25MG TABLET Actual shortage 2024-02-08 2024-04-25 218977
TEVA-CLONIDINE 0.2MG TABLET Resolved 2023-02-16 2023-10-04 184946
TEVA-CLONIDINE 0.2MG TABLET Resolved 2023-06-20 2023-07-05 195888
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-30 2021-04-01 127616
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-06 2021-01-28 128025
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-18 2021-05-13 134343
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-08 2021-05-13 137185
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-12-15 160454
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-04-27 2024-05-09 190785
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-10-06 195078
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195827
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-05-03 209148
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Resolved 2017-05-23 2017-09-19 10877
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86966

Showing 161 to 180 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2018-10-19 2018-10-19 64983
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
TEVA-CIPROFLOXACIN 500MG TABLET Discontinued 2017-06-27 2017-06-27 14049
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-25 2019-10-26 97248
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-31 2019-11-01 97589
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
TEVA-CLARITHROMYCIN 500MG TABLET Discontinued 2020-06-11 2020-06-11 117526
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-METOPROLOL 50MG TABLET Discontinued 2020-07-10 2020-07-10 119976
TEVA-AMITRIPTYLINE 50MG TABLET Discontinued 2020-10-22 2020-10-24 126900
TEVA-AMITRIPTYLINE 50MG TABLET Discontinued 2022-01-07 2022-01-07 152378
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350

Showing 201 to 220 of 250